81 related articles for article (PubMed ID: 12836616)
1. [Lymphocytes: what is "Vav"].
Charvet C; Deckert M
Med Sci (Paris); 2003 Feb; 19(2):217-22. PubMed ID: 12836616
[TBL] [Abstract][Full Text] [Related]
2. VAV proteins as signal integrators for multi-subunit immune-recognition receptors.
Turner M; Billadeau DD
Nat Rev Immunol; 2002 Jul; 2(7):476-86. PubMed ID: 12094222
[TBL] [Abstract][Full Text] [Related]
3. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
4. Vav-family proteins in T-cell signalling.
Tybulewicz VL
Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
[TBL] [Abstract][Full Text] [Related]
5. Cell growth and metastasis in pancreatic cancer: is Vav the Rho'd to activation?
Billadeau DD
Int J Gastrointest Cancer; 2002; 31(1-3):5-13. PubMed ID: 12622410
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
[TBL] [Abstract][Full Text] [Related]
7. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
[TBL] [Abstract][Full Text] [Related]
8. Vav proteins, adaptors and cell signaling.
Bustelo XR
Oncogene; 2001 Oct; 20(44):6372-81. PubMed ID: 11607839
[TBL] [Abstract][Full Text] [Related]
9. RhoG regulates gene expression and the actin cytoskeleton in lymphocytes.
Vigorito E; Billadeu DD; Savoy D; McAdam S; Doody G; Fort P; Turner M
Oncogene; 2003 Jan; 22(3):330-42. PubMed ID: 12545154
[TBL] [Abstract][Full Text] [Related]
10. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes.
Ramos-Morales F; Druker BJ; Fischer S
Oncogene; 1994 Jul; 9(7):1917-23. PubMed ID: 8208538
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells.
Gulbins E; Langlet C; Baier G; Bonnefoy-Berard N; Herbert E; Altman A; Coggeshall KM
J Immunol; 1994 Mar; 152(5):2123-9. PubMed ID: 8133029
[TBL] [Abstract][Full Text] [Related]
12. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
13. Vav: function and regulation in hematopoietic cell signaling.
Bonnefoy-Bérard N; Munshi A; Yron I; Wu S; Collins TL; Deckert M; Shalom-Barak T; Giampa L; Herbert E; Hernandez J; Meller N; Couture C; Altman A
Stem Cells; 1996 May; 14(3):250-68. PubMed ID: 8724692
[TBL] [Abstract][Full Text] [Related]
14. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
Hu P; Margolis B; Schlessinger J
Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
16. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
17. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42.
Movilla N; Dosil M; Zheng Y; Bustelo XR
Oncogene; 2001 Dec; 20(56):8057-65. PubMed ID: 11781818
[TBL] [Abstract][Full Text] [Related]
18. A Cdc42 mutant specifically activated by intersectin.
Smith WJ; Hamel B; Yohe ME; Sondek J; Cerione RA; Snyder JT
Biochemistry; 2005 Oct; 44(40):13282-90. PubMed ID: 16201754
[TBL] [Abstract][Full Text] [Related]
19. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.
Bellanger JM; Astier C; Sardet C; Ohta Y; Stossel TP; Debant A
Nat Cell Biol; 2000 Dec; 2(12):888-92. PubMed ID: 11146652
[TBL] [Abstract][Full Text] [Related]
20. GEF at work: Vav in protruding filopodia.
Kranewitter WJ; Danninger C; Gimona M
Cell Motil Cytoskeleton; 2001 Jul; 49(3):154-60. PubMed ID: 11668584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
